Molecular target therapy for bone metastasis: Starting a new era with denosumab, a RANKL inhibitor

  1. Rolfo, C.
  2. Raez, L.E.
  3. Russo, A.
  4. Reguart, N.
  5. Campelo, R.G.
  6. Bronte, G.
  7. Papadimitriou, K.
  8. Silvestris, F.
Journal:
Expert Opinion on Biological Therapy

ISSN: 1471-2598

Year of publication: 2014

Volume: 14

Issue: 1

Pages: 15-26

Type: Review

DOI: 10.1517/14712598.2013.843667 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus